Lilly(Eli) & Co

NYSE:LLY   4:00:00 PM EDT
+3.65 (+1.07%)
5:22:17 PM EDT: $343.50 -0.65 (-0.19%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)339.71B
Current PE56.31
Forward PE 44.24
2yr Forward PE 41.31
See more stats
Estimates Current Quarter
Revenue$7.37 Billion
Adjusted EPS$1.92
See more estimates
10-Day MA$346.89
50-Day MA$360.09
200-Day MA$326.65
See more pivots

Lilly(Eli) & Co Stock, NYSE:LLY

Lilly Corporate Center, Indianapolis, Indiana 46285
United States of America
Phone: +1.317.276.2000
Number of Employees: 35000


Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. The firm's products consist of Diabetes, Oncology, Immunology, Neuroscience, and Other therapies. The Diabetes products include Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta, and Trulicity. The Oncology products consist of Alimta, Cyramza, Erbitux, Retevmo, Tyvyt, and Verzenio. The Immunology products include Olumiant and Taltz. The Neuroscience products consist of Cymbalta, Emgality, Reyvow, and Zyprexa. The Other therapies include Bamlanivimab, Cialis, and Forteo. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.